Antihypertensive drug development: current challenges and future opportunities-Reference-Cited by-同舟云学术

Antihypertensive drug development: current challenges and future opportunities

Published:2010-07 Issue:4 Volume:4 Page:163-173
ISSN:1933-1711
Container-title:Journal of the American Society of Hypertension
language:en
Short-container-title:Journal of the American Society of Hypertension

Author:

Feig Peter U.,Roy Sophie,Cody Robert J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Internal Medicine

Reference45 articles.

1. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000;Hajjar;JAMA,2003

2. U.S. product circular for Tekturna (aliskiren). Available online at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021985lbl.pdf. Accessed April 26, 2010.

3. The value of improving the productivity of the drug development process: faster times and better decisions;DiMasi;Pharmacoeconomics,2002

4. The price of innovation: new estimates of drug development costs;DiMasi;J Health Econ,2003

5. Estimating the cost of new drug development: is it really $802 million?;Adams;Health Affairs,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QSPR analysis of drugs for anti-hypertension using degree based topological indices through M-polynomial and NM-polynomial;2023-11-30

2. Methods of Blood Pressure Assessment Used in Milestone Hypertension Trials;Management of Hypertension;2018-11-20

3. Exploring the C-domain inhibition of angiotensin converting enzyme through novel bradykinin potentiating peptides;Pharmacy & Pharmacology International Journal;2018-11-09

4. Rationale and evidence for the development of a durable device-based cardiac neuromodulation therapy for hypertension;Journal of the American Society of Hypertension;2018-05

5. Methods of Blood Pressure Assessment Used in Milestone Hypertension Trials;Pulse;2018